1,623 results on '"DEL PRATO, Stefano"'
Search Results
2. Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care
3. GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes
4. Continuous glucose monitoring for the routine care of type 2 diabetes mellitus
5. 2024: The year to take European action on diabetes to the next level
6. Impact of baseline FIB-4 score on efpeglenatide benefits on cardiovascular outcomes in people with type 2 diabetes: a participant-level exploratory analysis of the AMPLITUDE-O trial
7. Relationship between NT-proBNP, echocardiographic abnormalities and functional status in patients with subclinical siabetic cardiomyopathy
8. Fatty liver index is an independent risk factor for all-cause mortality and major cardiovascular events in type 1 diabetes: an 11-year observational study
9. Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial
10. An Italian MODY family with proband and son carrying variants in GCK and HFN1A: is it a true case of digenic MODY?
11. DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases
12. Incretins and cardiovascular disease: to the heart of type 2 diabetes?
13. Racial Differences in Diabetic Cardiomyopathy: The ARISE-HF Trial
14. Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy
15. The current landscape for diabetes treatment: Preventing diabetes-associated CV risk
16. Indirect effects of the COVID-19 pandemic on diagnosing, monitoring, and prescribing in people with diabetes and strategies for diabetes service recovery internationally
17. Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk
18. The European Diabetes Forum (EUDF): a forum for turning the tide on diabetes in Europe
19. GLP-1 Receptor Agonist Therapy With and Without SGLT2 Inhibitors in Patients With Type 2 Diabetes
20. De-intensification of basal-bolus insulin regimen after initiation of a GLP-1 RA improves glycaemic control and promotes weight loss in subjects with type 2 diabetes
21. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
22. Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy
23. The density of crown-like structures in epicardial adipose tissue could play a role in cardiovascular diseases
24. Brain effect of bariatric surgery in people with obesity
25. Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis
26. The relationship between dietary patterns and glycemic variability in people with impaired glucose tolerance
27. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
28. The Place and Value of Sodium-Glucose Cotransporter 2 Inhibitors in the Evolving Treatment Paradigm for Type 2 Diabetes Mellitus: A Narrative Review
29. The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery
30. Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life history
31. Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial
32. Ruolo delle adipochine nella patogenesi del diabete gestazionale
33. Glucose tolerance and markers of myocardial injury after an acute coronary syndrome: predictive role of the 1-h plus 2-h plasma glucose at the oral glucose tolerance test
34. The IGFBP3/TMEM219 pathway regulates beta cell homeostasis
35. MG53 marks poor beta cell performance and predicts onset of type 2 diabetes in subjects with different degrees of glucose tolerance.
36. Insulin discovery: A pivotal point in medical history
37. Women in diabetes research: we can do better. Reply to Bonnefond A [letter]
38. The role of incretin receptor agonists in the treatment of obesity.
39. Cost–utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy—An Italian healthcare system perspective.
40. Basal weekly insulins: the way of the future!
41. Beta-cell function, incretin effect and glucose kinetics in response to a mixed meal in patients with type 2 diabetes treated with dapagliflozin plus saxagliptin
42. β-Cell Function, Incretin Effect, and Glucose Kinetics in Response to a Mixed Meal in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin
43. Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk
44. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
45. Effect of albiglutide on cardiovascular outcomes in older adults: A post hoc analysis of a randomized controlled trial
46. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
47. Glycaemic control during the lockdown for COVID-19 in adults with type 1 diabetes: A meta-analysis of observational studies
48. Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID Future
49. Bariatric surgery restores visual cortical plasticity in nondiabetic subjects with obesity
50. Risk factors associated with postpartum impaired glucose regulation in women with previous gestational diabetes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.